Do You Believe in the Growth Potential of Orthofix Medical (OFIX)?

Group 1: Rewey Asset Management Overview - Rewey Asset Management's "RAM Smid Composite" increased by 6.11% in Q2 2025, slightly underperforming the benchmark Russell 2500 Value Total Return Index, which gained 7.29% [1] - Year-to-date, the composite returned -1.29%, compared to a 1.03% gain for the benchmark [1] - The firm expresses confidence in the Smid value sector as it approaches the second half of 2025 [1] Group 2: Orthofix Medical Inc. Analysis - Orthofix Medical Inc. (NASDAQ:OFIX) is highlighted as a key stock, with a one-month return of 2.76% and a 52-week loss of 9.80% [2] - As of September 12, 2025, Orthofix's stock closed at $14.91 per share, with a market capitalization of $588.86 million [2] - Rewey Asset Management increased its position in Orthofix Medical Inc. in Q2 2025, following a 45.6% decline from its February high and a 36.1% drop from its 2024 close, viewing it as a compelling valuation opportunity [3] Group 3: Hedge Fund Interest and Comparisons - Orthofix Medical Inc. was held by 25 hedge fund portfolios at the end of Q2 2025, down from 28 in the previous quarter [4] - While Orthofix is acknowledged for its investment potential, the firm believes certain AI stocks present greater upside potential and less downside risk [4]